Keywords: PDL BioPharma, Royalaties, Roche, Genentech, Avastin, Herceptin, Lucentis, Xolair

PDL BioPharma sues Roche’s Genentech over royalties

Article | 02 September 2010

Print This

US drug developer PDL BioPharma (Nasdaq: PDL) said yesterday that it has filed suit in a Nevada state court to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in